2 weeks Rigel Pharmaceuticals (RIGL) Surpasses Q4 Earnings and Revenue Estimates Zacks
Rigel (RIGL) delivered earnings and revenue surprises of 45.45% and 0.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
X